» Articles » PMID: 34065630

Aconitine Neurotoxicity According to Administration Methods

Overview
Journal J Clin Med
Specialty General Medicine
Date 2021 Jun 2
PMID 34065630
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

We evaluated the toxic effects of aconitine on the human nervous system and its associated factors, and the general clinical characteristics of patients who visited the emergency room due to aconitine intoxication between 2008 and 2017. We also analyzed the differences related to aconitine processing and administration methods (oral pill, boiled in water, and alcohol-soaked), and the clinical characteristics of consciousness deterioration and neurological symptoms. Of the 41 patients who visited the hospital due to aconitine intoxication, 23 (56.1%) were female, and most were older. Aconitine was mainly used for pain control (28 patients, 68.3%) and taken as oral pills (19 patients, 46%). The patients showed a single symptom or a combination of symptoms; neurological symptoms were the most common (21 patients). All patients who took aconitine after processing with alcohol showed neurological symptoms and a higher prevalence of consciousness deterioration. Neurological symptoms occurred most frequently in patients with aconitine intoxication. Although aconitine intoxication presents with various symptoms, its prognosis may vary with the processing method and prevalence of consciousness deterioration during the early stages. Therefore, the administration method and accompanying symptoms should be comprehensively investigated in patients who have taken aconitine to facilitate prompt and effective treatment and better prognoses.

Citing Articles

Clinical research on the effectiveness and safety of Uchasingihwan for low back pain with radiculopathy caused by herniated intervertebral disc of the lumbar spine: A multicenter, randomized, controlled equivalence trial.

Goo B, Kim J, Kim E, Nam D, Lee H, Kim J Integr Med Res. 2024; 13(4):101090.

PMID: 39640075 PMC: 11617728. DOI: 10.1016/j.imr.2024.101090.


Screening tools to evaluate the neurotoxic potential of botanicals: building a strategy to assess safety.

Kanungo J, Sorkin B, Krzykwa J, Mitchell C, Embry M, Spencer P Expert Opin Drug Metab Toxicol. 2024; 20(7):629-646.

PMID: 38984683 PMC: 11542175. DOI: 10.1080/17425255.2024.2378895.


Involvement of autophagy in mesaconitine-induced neurotoxicity in HT22 cells revealed through integrated transcriptomic, proteomic, and m6A epitranscriptomic profiling.

Lin X, Zhang J, Wu Z, Shi Y, Chen M, Li M Front Pharmacol. 2024; 15:1393717.

PMID: 38939838 PMC: 11208636. DOI: 10.3389/fphar.2024.1393717.


Neuropharmacological Potential of Diterpenoid Alkaloids.

Salehi A, Ghanadian M, Zolfaghari B, Jassbi A, Fattahian M, Reisi P Pharmaceuticals (Basel). 2023; 16(5).

PMID: 37242531 PMC: 10223254. DOI: 10.3390/ph16050747.


Study on the Mechanism of Mesaconitine-Induced Hepatotoxicity in Rats Based on Metabonomics and Toxicology Network.

Chen Q, Zhang K, Jiao M, Jiao J, Chen D, Yin Y Toxins (Basel). 2022; 14(7).

PMID: 35878224 PMC: 9322933. DOI: 10.3390/toxins14070486.


References
1.
Chan T . Aconitum alkaloid content and the high toxicity of aconite tincture. Forensic Sci Int. 2012; 222(1-3):1-3. DOI: 10.1016/j.forsciint.2012.02.026. View

2.
Chan T . Aconitine poisoning: a global perspective. Vet Hum Toxicol. 1994; 36(4):326-8. View

3.
Ameri A . Effects of the Aconitum alkaloid songorine on synaptic transmission and paired-pulse facilitation of CA1 pyramidal cells in rat hippocampal slices. Br J Pharmacol. 1998; 125(3):461-8. PMC: 1565649. DOI: 10.1038/sj.bjp.0702100. View

4.
Yeih D, Chiang F, Huang S . Successful treatment of aconitine induced life threatening ventricular tachyarrhythmia with amiodarone. Heart. 2000; 84(4):E8. PMC: 1729459. DOI: 10.1136/heart.84.4.e8. View

5.
Sato H, Ohizumi Y, Hikino H . Mechanism of mesaconitine-induced contractile response in guinea pig vas deferens. Eur J Pharmacol. 1979; 55(1):83-92. DOI: 10.1016/0014-2999(79)90150-x. View